VIRX

Viracta Therapeutics, Inc. Common Stock

Delisted

VIRX was delisted on the 3rd of February, 2025.

41 hedge funds and large institutions have $14.1M invested in Viracta Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

36% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 11

64% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 11

Holders
41
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9K
Puts
$3K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$5.1M
2
$2.14M
3
$1.62M
4
$984K
5
$972K
6
$649K
7
$434K
8
$407K
9
$316K
10
$235K
11
$190K
12
$176K
13
$92.9K
14
$89.4K
15
$83K
16
$77K
17
$74.6K
18
$67.3K
19
$59K
20
$54.3K
21
$49.4K
22
$25.4K
23
$24K
24
$23.7K
25
$19.7K